New Survey: Consumers Hold Drug Companies Responsible for High Prices and Out-of-Pocket Costs
November 30, 2016
(Washington, D.C.) — A new national survey finds most voters blame drug companies not only for high drug prices, but...
Filter by:
Drug Cost Management
Filter by Year:Clear Filters- Press Releases
- Biosimilars
- Drug Abuse Prevention
- Drug Adherence Programs
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Employers, Unions, & Insurers
- FEHBP Program
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Health Insurance Marketplace (ACA)
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- REMS Management
- Specialty Benefit Design
- Specialty Pharmacies
- Specialty Pharmacy Networks
- TRICARE
- Value & Outcomes-Based Contracting
New Research: PBMs Save $941 Per Person Annually
November 28, 2016
(Washington, D.C.) — Pharmacy benefit managers (PBMs) are saving consumers and payers an average of $941 per person per year,...
PCMA on New Bureau of Labor Statistics Data: Competition is the Key to Lowering High Drug Prices
October 19, 2016
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt issued the following statement regarding drug price...
PCMA Statement on Oversight Committee Hearing on EpiPen Price Hikes
September 21, 2016
(Washington, D.C.) —Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt issued the following statement on today’s House Committee...
September 20, 2016
A new report, “Comparison of Hepatitis C Treatment Costs,” shows Hepatitis C drug prices, specifically negotiated by pharmacy benefit managers...
Survey on Drug Costs: Employers Prefer Private Sector Solutions
September 13, 2016
(Washington, D.C.) — America’s employers are concerned about high drug prices and think private sector solutions would address the issue...
August 25, 2016
Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt issued the following statement on Mylan’s EpiPen price hikes and...
PCMA Applauds Passage of CARA to Fight Prescription Drug and Opioid Abuse
July 14, 2016
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) appreciates the work of the House and Senate on passage of...
PCMA: CREATES Act to Increase Access to Generic Drugs
June 21, 2016
(Washington, D.C.) — Today’s Senate Judiciary Subcommittee hearing on S. 3056, the Creating and Restoring Equal Access to Equivalent Samples...
PCMA on New PwC Report: PBMs Driving Competition to Reduce Drug Costs
June 21, 2016
(Washington, D.C.) — The new PwC Health Research Institute (HRI) annual report (“Medical Cost Trend: Behind the Numbers 2017”) highlights...
NY Legislation Grants Drugstores a ‘Free Pass’ to Evade Patient Safety & Performance Standards
June 08, 2016
(Washington, D.C.)— New York state legislation (S.2530 and A.6194) that creates a special exemption for drugstores from certain safety...
The Independent Drugstore Lobby Agenda: Higher Drug Prices, Fewer Choices in Medicare
May 23, 2016
(Washington, D.C.) — As the independent drugstore lobby descends on Capitol Hill this week to push an agenda that...